Luther King Capital Management (LKCM)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-572
Closed -$201K 613
2023
Q2
$201K Sell
572
-682
-54% -$240K ﹤0.01% 577
2023
Q1
$395K Buy
1,254
+6
+0.5% +$1.89K ﹤0.01% 487
2022
Q4
$360K Buy
1,248
+31
+3% +$8.95K ﹤0.01% 494
2022
Q3
$352K Buy
1,217
+270
+29% +$78.1K ﹤0.01% 489
2022
Q2
$267K Buy
+947
New +$267K ﹤0.01% 557